Education Library

Resources for Health Care Professionals

Filter Results

Condition

Audience

Topic

Type

2024 Q2 Critical Care Transport Update Webinar

Jena Billig discusses right ventricular (RV) failure and right-sided Impella devices in this critical care transport webinar.

Impella ECP Pivotal Study: First Results

Amir Kaki, M.D., describes the first results from the Impella ECP Pivotal Study.

DanGer Shock Discussion with Jacob Møller at TCT 2024

Jacob Møller, M.D., and Chuck Simonton, M.D., discuss the DanGer Shock RCT and new data presented at TCT 2024.

TCT 2024: Shockwave Innovations

Nick West, M.D., CMO at Shockwave, discusses Shockwave innovations presented at TCT 2024.

DanGer Shock Randomized Control Trial FAQs

The significance of the DanGer Shock trial lies in its milestone findings for cardiology, potentially reshaping patient care by establishing routine Impella use as a life-saving intervention for STEMI patients with shock.

Educational Grant Frequently Asked Questions

The following is provided for informational purposes to organizations that are considering applying for an Abiomed Educational Grant. 

Ripped From the Headlines of ACC: DanGer Shock RCT Results

A panel of interventional cardiologists discuss the DanGer Shock RCT results and the implications for AMICS patient management.

European Best Practice A Step Forward to Optimize Impella-Protected Percutaneous Coronary Intervention To Improve Outcomes After High-Risk Coronary Interventions

This overview article provides a framework for this series of articles. It addresses European recommendations and best practices for patient management and mechanical circulatory support (MCS) during high risk intervention, highlighting the following topics...

Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients - A Glimpse into the Future

This article examines current evidence for the use of mechanical circulatory support (MCS) in cardiogenic shock and discusses how the scientific community can advance research in this area.

Successful Mechanical Circulatory Support (MCS) in Cardiogenic Shock Patients

Experts throughout Europe have contributed to this European Heart Journal supplement with articles discussing best practices for successfully managing mechanical circulatory support (MCS) in patients with cardiogenic shock.

Recognizing Patients as Candidates for Mechanical Circulatory Support Along the Spectrum of Cardiogenic Shock

This paper discusses the latest guidance for identifying patients with cardiogenic shock (CS) who are candidates for mechanical circulatory support (MCS).

Optimal Bail-Out and Complication Management Strategies in Protected High-Risk Percutaneous Coronary Intervention With the Impella Heart Pump

In this article the authors describe techniques for Impella heart pump removal with or without pre-closure and discuss how to prevent and manage complications associated with large-bore femoral access.

Handling High-Risk Patients in the Catheterization Laboratory

This article describes how the interventional cardiology team handles high-risk patients in the cath lab, from procedural preparation and planning through procedural monitoring, as well as weaning strategies and access site management.

Case Presentation by Alan Gass, M.D., FACC

Alan Gass, M.D., FACC from Westchester Medical Center presents a case of a 48-year-old male without prior medical history who presented to a local hospital with several hours of chest pain.

EuroPCR 2023: How To Optimize High-Risk PCI Patient Outcome: Discussion and Audience Interaction

Javier Escaned, MD, Nikos Werner, MD, Dirk Westermann, MD, and Vasileios Panoulas, MD, answer questions following the EuroPCR session “How to optimize high-risk patient outcome?”

NPS-1674

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].